drugset / Trial / NCT02048293

Pharmacodynamic Differences Between Branded and Unbranded Remifentanil Molecules

NCT02048293 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Unbranded drug molecules are produced after the patent of a given drug has expired. Unbranded molecules of Remifentanil have been marketed in Colombia, and several reports by anesthesiologist indicate that there are differences in the physiologic response of patients to these molecules. The investigators hypothesized that unbranded molecules of remifentanil require higher doses to obtain desired physiological responses as compared to the branded molecule.

Timeline

Start
2012-10
Primary completion
2013-10
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Remifentanil Small molecule 6 ng/ml —
Comparator Remifentanil Small molecule 8 ng/ml —
Comparator Remifentanil Small molecule 10 ng/ml —

Indications

No indication recorded.